Tsuruha Holdings Inc.
Tsuruha Holdings Inc. (TSUSF) Stock Competitors & Peer Comparison
See (TSUSF) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Pharmaceuticals Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| TSUSF | $17.25 | +0.00% | 4.2B | 41.07 | $0.42 | +5.95% |
| ALBHF | $0.61 | -5.41% | 9.8B | 30.32 | $0.02 | N/A |
| ALBBY | $12.12 | +20.60% | 9.8B | 34.63 | $0.35 | N/A |
| RADLY | $4.25 | -4.71% | 7.4B | 28.33 | $0.15 | +1.92% |
| MSMKF | $18.17 | +0.00% | 7.2B | 19.75 | $0.92 | +1.80% |
| RGEDF | $31.00 | +0.00% | 5.7B | 8.68 | $3.57 | +4.19% |
| DCHPF | $46.90 | -0.21% | 5.3B | -151.29 | -$0.31 | N/A |
| GEDSF | $24.85 | +0.00% | 4.5B | 10.71 | $2.32 | +5.69% |
| CLCGY | $35.16 | +0.04% | 4.1B | 21.84 | $1.61 | +2.46% |
| CSMYF | $48.27 | +0.00% | 3.8B | 19.23 | $2.51 | +1.04% |
Stock Comparison
TSUSF vs ALBHF Comparison April 2026
TSUSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSUSF stands at 4.2B. In comparison, ALBHF has a market cap of 9.8B. Regarding current trading prices, TSUSF is priced at $17.25, while ALBHF trades at $0.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSUSF currently has a P/E ratio of 41.07, whereas ALBHF's P/E ratio is 30.32. In terms of profitability, TSUSF's ROE is +0.12%, compared to ALBHF's ROE of +0.18%. Regarding short-term risk, TSUSF is less volatile compared to ALBHF. This indicates potentially lower risk in terms of short-term price fluctuations for TSUSF.Check ALBHF's competition here
TSUSF vs ALBBY Comparison April 2026
TSUSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSUSF stands at 4.2B. In comparison, ALBBY has a market cap of 9.8B. Regarding current trading prices, TSUSF is priced at $17.25, while ALBBY trades at $12.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSUSF currently has a P/E ratio of 41.07, whereas ALBBY's P/E ratio is 34.63. In terms of profitability, TSUSF's ROE is +0.12%, compared to ALBBY's ROE of +0.18%. Regarding short-term risk, TSUSF is less volatile compared to ALBBY. This indicates potentially lower risk in terms of short-term price fluctuations for TSUSF.Check ALBBY's competition here
TSUSF vs RADLY Comparison April 2026
TSUSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSUSF stands at 4.2B. In comparison, RADLY has a market cap of 7.4B. Regarding current trading prices, TSUSF is priced at $17.25, while RADLY trades at $4.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSUSF currently has a P/E ratio of 41.07, whereas RADLY's P/E ratio is 28.33. In terms of profitability, TSUSF's ROE is +0.12%, compared to RADLY's ROE of +0.19%. Regarding short-term risk, TSUSF is less volatile compared to RADLY. This indicates potentially lower risk in terms of short-term price fluctuations for TSUSF.Check RADLY's competition here
TSUSF vs MSMKF Comparison April 2026
TSUSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSUSF stands at 4.2B. In comparison, MSMKF has a market cap of 7.2B. Regarding current trading prices, TSUSF is priced at $17.25, while MSMKF trades at $18.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSUSF currently has a P/E ratio of 41.07, whereas MSMKF's P/E ratio is 19.75. In terms of profitability, TSUSF's ROE is +0.12%, compared to MSMKF's ROE of +0.11%. Regarding short-term risk, TSUSF is less volatile compared to MSMKF. This indicates potentially lower risk in terms of short-term price fluctuations for TSUSF.Check MSMKF's competition here
TSUSF vs RGEDF Comparison April 2026
TSUSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSUSF stands at 4.2B. In comparison, RGEDF has a market cap of 5.7B. Regarding current trading prices, TSUSF is priced at $17.25, while RGEDF trades at $31.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSUSF currently has a P/E ratio of 41.07, whereas RGEDF's P/E ratio is 8.68. In terms of profitability, TSUSF's ROE is +0.12%, compared to RGEDF's ROE of +0.17%. Regarding short-term risk, TSUSF and RGEDF have similar daily volatility (0.00).Check RGEDF's competition here
TSUSF vs DCHPF Comparison April 2026
TSUSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSUSF stands at 4.2B. In comparison, DCHPF has a market cap of 5.3B. Regarding current trading prices, TSUSF is priced at $17.25, while DCHPF trades at $46.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSUSF currently has a P/E ratio of 41.07, whereas DCHPF's P/E ratio is -151.29. In terms of profitability, TSUSF's ROE is +0.12%, compared to DCHPF's ROE of -0.04%. Regarding short-term risk, TSUSF and DCHPF have similar daily volatility (0.00).Check DCHPF's competition here
TSUSF vs GEDSF Comparison April 2026
TSUSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSUSF stands at 4.2B. In comparison, GEDSF has a market cap of 4.5B. Regarding current trading prices, TSUSF is priced at $17.25, while GEDSF trades at $24.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSUSF currently has a P/E ratio of 41.07, whereas GEDSF's P/E ratio is 10.71. In terms of profitability, TSUSF's ROE is +0.12%, compared to GEDSF's ROE of +0.17%. Regarding short-term risk, TSUSF and GEDSF have similar daily volatility (0.00).Check GEDSF's competition here
TSUSF vs CLCGY Comparison April 2026
TSUSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSUSF stands at 4.2B. In comparison, CLCGY has a market cap of 4.1B. Regarding current trading prices, TSUSF is priced at $17.25, while CLCGY trades at $35.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSUSF currently has a P/E ratio of 41.07, whereas CLCGY's P/E ratio is 21.84. In terms of profitability, TSUSF's ROE is +0.12%, compared to CLCGY's ROE of +0.48%. Regarding short-term risk, TSUSF is less volatile compared to CLCGY. This indicates potentially lower risk in terms of short-term price fluctuations for TSUSF.Check CLCGY's competition here
TSUSF vs CSMYF Comparison April 2026
TSUSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSUSF stands at 4.2B. In comparison, CSMYF has a market cap of 3.8B. Regarding current trading prices, TSUSF is priced at $17.25, while CSMYF trades at $48.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSUSF currently has a P/E ratio of 41.07, whereas CSMYF's P/E ratio is 19.23. In terms of profitability, TSUSF's ROE is +0.12%, compared to CSMYF's ROE of +0.12%. Regarding short-term risk, TSUSF is less volatile compared to CSMYF. This indicates potentially lower risk in terms of short-term price fluctuations for TSUSF.Check CSMYF's competition here
TSUSF vs WLCGF Comparison April 2026
TSUSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSUSF stands at 4.2B. In comparison, WLCGF has a market cap of 3.4B. Regarding current trading prices, TSUSF is priced at $17.25, while WLCGF trades at $16.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSUSF currently has a P/E ratio of 41.07, whereas WLCGF's P/E ratio is 19.54. In terms of profitability, TSUSF's ROE is +0.12%, compared to WLCGF's ROE of +0.08%. Regarding short-term risk, TSUSF and WLCGF have similar daily volatility (0.00).Check WLCGF's competition here
TSUSF vs SDGCF Comparison April 2026
TSUSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSUSF stands at 4.2B. In comparison, SDGCF has a market cap of 3.3B. Regarding current trading prices, TSUSF is priced at $17.25, while SDGCF trades at $28.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSUSF currently has a P/E ratio of 41.07, whereas SDGCF's P/E ratio is 17.40. In terms of profitability, TSUSF's ROE is +0.12%, compared to SDGCF's ROE of +0.11%. Regarding short-term risk, TSUSF and SDGCF have similar daily volatility (0.00).Check SDGCF's competition here
TSUSF vs SGIPF Comparison April 2026
TSUSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSUSF stands at 4.2B. In comparison, SGIPF has a market cap of 2.9B. Regarding current trading prices, TSUSF is priced at $17.25, while SGIPF trades at $16.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSUSF currently has a P/E ratio of 41.07, whereas SGIPF's P/E ratio is 20.11. In terms of profitability, TSUSF's ROE is +0.12%, compared to SGIPF's ROE of +0.10%. Regarding short-term risk, TSUSF and SGIPF have similar daily volatility (0.00).Check SGIPF's competition here
TSUSF vs HTSUY Comparison April 2026
TSUSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSUSF stands at 4.2B. In comparison, HTSUY has a market cap of 1.9B. Regarding current trading prices, TSUSF is priced at $17.25, while HTSUY trades at $6.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSUSF currently has a P/E ratio of 41.07, whereas HTSUY's P/E ratio is N/A. In terms of profitability, TSUSF's ROE is +0.12%, compared to HTSUY's ROE of +0.07%. Regarding short-term risk, TSUSF and HTSUY have similar daily volatility (0.00).Check HTSUY's competition here
TSUSF vs SHPPF Comparison April 2026
TSUSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSUSF stands at 4.2B. In comparison, SHPPF has a market cap of 919M. Regarding current trading prices, TSUSF is priced at $17.25, while SHPPF trades at $45.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSUSF currently has a P/E ratio of 41.07, whereas SHPPF's P/E ratio is -20.92. In terms of profitability, TSUSF's ROE is +0.12%, compared to SHPPF's ROE of -0.08%. Regarding short-term risk, TSUSF is less volatile compared to SHPPF. This indicates potentially lower risk in terms of short-term price fluctuations for TSUSF.Check SHPPF's competition here
TSUSF vs SAEYY Comparison April 2026
TSUSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSUSF stands at 4.2B. In comparison, SAEYY has a market cap of 804.4M. Regarding current trading prices, TSUSF is priced at $17.25, while SAEYY trades at $4.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSUSF currently has a P/E ratio of 41.07, whereas SAEYY's P/E ratio is -19.05. In terms of profitability, TSUSF's ROE is +0.12%, compared to SAEYY's ROE of -0.08%. Regarding short-term risk, TSUSF is less volatile compared to SAEYY. This indicates potentially lower risk in terms of short-term price fluctuations for TSUSF.Check SAEYY's competition here
TSUSF vs BJTRF Comparison April 2026
TSUSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSUSF stands at 4.2B. In comparison, BJTRF has a market cap of 542.8M. Regarding current trading prices, TSUSF is priced at $17.25, while BJTRF trades at $0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSUSF currently has a P/E ratio of 41.07, whereas BJTRF's P/E ratio is 8.10. In terms of profitability, TSUSF's ROE is +0.12%, compared to BJTRF's ROE of +0.02%. Regarding short-term risk, TSUSF and BJTRF have similar daily volatility (0.00).Check BJTRF's competition here
TSUSF vs ZRSEF Comparison April 2026
TSUSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSUSF stands at 4.2B. In comparison, ZRSEF has a market cap of 497.5M. Regarding current trading prices, TSUSF is priced at $17.25, while ZRSEF trades at $10.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSUSF currently has a P/E ratio of 41.07, whereas ZRSEF's P/E ratio is -1.81. In terms of profitability, TSUSF's ROE is +0.12%, compared to ZRSEF's ROE of -0.30%. Regarding short-term risk, TSUSF is less volatile compared to ZRSEF. This indicates potentially lower risk in terms of short-term price fluctuations for TSUSF.Check ZRSEF's competition here
TSUSF vs MYCOF Comparison April 2026
TSUSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSUSF stands at 4.2B. In comparison, MYCOF has a market cap of 81.4M. Regarding current trading prices, TSUSF is priced at $17.25, while MYCOF trades at $1.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSUSF currently has a P/E ratio of 41.07, whereas MYCOF's P/E ratio is 0.87. In terms of profitability, TSUSF's ROE is +0.12%, compared to MYCOF's ROE of -0.15%. Regarding short-term risk, TSUSF is less volatile compared to MYCOF. This indicates potentially lower risk in terms of short-term price fluctuations for TSUSF.Check MYCOF's competition here
TSUSF vs NVACF Comparison April 2026
TSUSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSUSF stands at 4.2B. In comparison, NVACF has a market cap of 78.5M. Regarding current trading prices, TSUSF is priced at $17.25, while NVACF trades at $1.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSUSF currently has a P/E ratio of 41.07, whereas NVACF's P/E ratio is 31.60. In terms of profitability, TSUSF's ROE is +0.12%, compared to NVACF's ROE of +0.06%. Regarding short-term risk, TSUSF is less volatile compared to NVACF. This indicates potentially lower risk in terms of short-term price fluctuations for TSUSF.Check NVACF's competition here
TSUSF vs FFLWF Comparison April 2026
TSUSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSUSF stands at 4.2B. In comparison, FFLWF has a market cap of 5.4M. Regarding current trading prices, TSUSF is priced at $17.25, while FFLWF trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSUSF currently has a P/E ratio of 41.07, whereas FFLWF's P/E ratio is -0.08. In terms of profitability, TSUSF's ROE is +0.12%, compared to FFLWF's ROE of -0.97%. Regarding short-term risk, TSUSF is less volatile compared to FFLWF. This indicates potentially lower risk in terms of short-term price fluctuations for TSUSF.Check FFLWF's competition here
TSUSF vs HEWA Comparison April 2026
TSUSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSUSF stands at 4.2B. In comparison, HEWA has a market cap of 5.1M. Regarding current trading prices, TSUSF is priced at $17.25, while HEWA trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSUSF currently has a P/E ratio of 41.07, whereas HEWA's P/E ratio is -4.00. In terms of profitability, TSUSF's ROE is +0.12%, compared to HEWA's ROE of -0.08%. Regarding short-term risk, TSUSF is less volatile compared to HEWA. This indicates potentially lower risk in terms of short-term price fluctuations for TSUSF.Check HEWA's competition here
TSUSF vs PNPL Comparison April 2026
TSUSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSUSF stands at 4.2B. In comparison, PNPL has a market cap of 3.1M. Regarding current trading prices, TSUSF is priced at $17.25, while PNPL trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSUSF currently has a P/E ratio of 41.07, whereas PNPL's P/E ratio is -4.20. In terms of profitability, TSUSF's ROE is +0.12%, compared to PNPL's ROE of +0.10%. Regarding short-term risk, TSUSF and PNPL have similar daily volatility (0.00).Check PNPL's competition here
TSUSF vs SYDRF Comparison April 2026
TSUSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSUSF stands at 4.2B. In comparison, SYDRF has a market cap of 2.9M. Regarding current trading prices, TSUSF is priced at $17.25, while SYDRF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSUSF currently has a P/E ratio of 41.07, whereas SYDRF's P/E ratio is 10.00. In terms of profitability, TSUSF's ROE is +0.12%, compared to SYDRF's ROE of -0.42%. Regarding short-term risk, TSUSF and SYDRF have similar daily volatility (0.00).Check SYDRF's competition here
TSUSF vs GABLF Comparison April 2026
TSUSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSUSF stands at 4.2B. In comparison, GABLF has a market cap of 2.7M. Regarding current trading prices, TSUSF is priced at $17.25, while GABLF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSUSF currently has a P/E ratio of 41.07, whereas GABLF's P/E ratio is -0.04. In terms of profitability, TSUSF's ROE is +0.12%, compared to GABLF's ROE of +2.91%. Regarding short-term risk, TSUSF and GABLF have similar daily volatility (0.00).Check GABLF's competition here
TSUSF vs ETBI Comparison April 2026
TSUSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSUSF stands at 4.2B. In comparison, ETBI has a market cap of 2.1M. Regarding current trading prices, TSUSF is priced at $17.25, while ETBI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSUSF currently has a P/E ratio of 41.07, whereas ETBI's P/E ratio is -0.10. In terms of profitability, TSUSF's ROE is +0.12%, compared to ETBI's ROE of +0.41%. Regarding short-term risk, TSUSF is less volatile compared to ETBI. This indicates potentially lower risk in terms of short-term price fluctuations for TSUSF.Check ETBI's competition here
TSUSF vs RLLVF Comparison April 2026
TSUSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSUSF stands at 4.2B. In comparison, RLLVF has a market cap of 2M. Regarding current trading prices, TSUSF is priced at $17.25, while RLLVF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSUSF currently has a P/E ratio of 41.07, whereas RLLVF's P/E ratio is -0.60. In terms of profitability, TSUSF's ROE is +0.12%, compared to RLLVF's ROE of +2.21%. Regarding short-term risk, TSUSF is less volatile compared to RLLVF. This indicates potentially lower risk in terms of short-term price fluctuations for TSUSF.Check RLLVF's competition here
TSUSF vs IWINF Comparison April 2026
TSUSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSUSF stands at 4.2B. In comparison, IWINF has a market cap of 1.7M. Regarding current trading prices, TSUSF is priced at $17.25, while IWINF trades at $0.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSUSF currently has a P/E ratio of 41.07, whereas IWINF's P/E ratio is -0.06. In terms of profitability, TSUSF's ROE is +0.12%, compared to IWINF's ROE of -0.21%. Regarding short-term risk, TSUSF and IWINF have similar daily volatility (0.00).Check IWINF's competition here
TSUSF vs LGNZZ Comparison April 2026
TSUSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSUSF stands at 4.2B. In comparison, LGNZZ has a market cap of 1.4M. Regarding current trading prices, TSUSF is priced at $17.25, while LGNZZ trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSUSF currently has a P/E ratio of 41.07, whereas LGNZZ's P/E ratio is N/A. In terms of profitability, TSUSF's ROE is +0.12%, compared to LGNZZ's ROE of +0.14%. Regarding short-term risk, TSUSF and LGNZZ have similar daily volatility (0.00).Check LGNZZ's competition here
TSUSF vs NUTTQ Comparison April 2026
TSUSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSUSF stands at 4.2B. In comparison, NUTTQ has a market cap of 1.1M. Regarding current trading prices, TSUSF is priced at $17.25, while NUTTQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSUSF currently has a P/E ratio of 41.07, whereas NUTTQ's P/E ratio is N/A. In terms of profitability, TSUSF's ROE is +0.12%, compared to NUTTQ's ROE of +3.01%. Regarding short-term risk, TSUSF is less volatile compared to NUTTQ. This indicates potentially lower risk in terms of short-term price fluctuations for TSUSF.Check NUTTQ's competition here
TSUSF vs CAFS Comparison April 2026
TSUSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSUSF stands at 4.2B. In comparison, CAFS has a market cap of 939.1K. Regarding current trading prices, TSUSF is priced at $17.25, while CAFS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSUSF currently has a P/E ratio of 41.07, whereas CAFS's P/E ratio is 0.49. In terms of profitability, TSUSF's ROE is +0.12%, compared to CAFS's ROE of +1.94%. Regarding short-term risk, TSUSF is less volatile compared to CAFS. This indicates potentially lower risk in terms of short-term price fluctuations for TSUSF.Check CAFS's competition here
TSUSF vs LGNYZ Comparison April 2026
TSUSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSUSF stands at 4.2B. In comparison, LGNYZ has a market cap of 737.8K. Regarding current trading prices, TSUSF is priced at $17.25, while LGNYZ trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSUSF currently has a P/E ratio of 41.07, whereas LGNYZ's P/E ratio is N/A. In terms of profitability, TSUSF's ROE is +0.12%, compared to LGNYZ's ROE of +0.14%. Regarding short-term risk, TSUSF and LGNYZ have similar daily volatility (0.00).Check LGNYZ's competition here
TSUSF vs CNBI Comparison April 2026
TSUSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSUSF stands at 4.2B. In comparison, CNBI has a market cap of 686.8K. Regarding current trading prices, TSUSF is priced at $17.25, while CNBI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSUSF currently has a P/E ratio of 41.07, whereas CNBI's P/E ratio is N/A. In terms of profitability, TSUSF's ROE is +0.12%, compared to CNBI's ROE of +0.17%. Regarding short-term risk, TSUSF is less volatile compared to CNBI. This indicates potentially lower risk in terms of short-term price fluctuations for TSUSF.Check CNBI's competition here
TSUSF vs RADCQ Comparison April 2026
TSUSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSUSF stands at 4.2B. In comparison, RADCQ has a market cap of 559.7K. Regarding current trading prices, TSUSF is priced at $17.25, while RADCQ trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSUSF currently has a P/E ratio of 41.07, whereas RADCQ's P/E ratio is -0.00. In terms of profitability, TSUSF's ROE is +0.12%, compared to RADCQ's ROE of +3.01%. Regarding short-term risk, TSUSF is less volatile compared to RADCQ. This indicates potentially lower risk in terms of short-term price fluctuations for TSUSF.Check RADCQ's competition here
TSUSF vs MMDCF Comparison April 2026
TSUSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSUSF stands at 4.2B. In comparison, MMDCF has a market cap of 541.2K. Regarding current trading prices, TSUSF is priced at $17.25, while MMDCF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSUSF currently has a P/E ratio of 41.07, whereas MMDCF's P/E ratio is N/A. In terms of profitability, TSUSF's ROE is +0.12%, compared to MMDCF's ROE of N/A. Regarding short-term risk, TSUSF and MMDCF have similar daily volatility (0.00).Check MMDCF's competition here
TSUSF vs BIEI Comparison April 2026
TSUSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSUSF stands at 4.2B. In comparison, BIEI has a market cap of 500K. Regarding current trading prices, TSUSF is priced at $17.25, while BIEI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSUSF currently has a P/E ratio of 41.07, whereas BIEI's P/E ratio is -0.05. In terms of profitability, TSUSF's ROE is +0.12%, compared to BIEI's ROE of +0.01%. Regarding short-term risk, TSUSF is less volatile compared to BIEI. This indicates potentially lower risk in terms of short-term price fluctuations for TSUSF.Check BIEI's competition here
TSUSF vs AEGY Comparison April 2026
TSUSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSUSF stands at 4.2B. In comparison, AEGY has a market cap of 411.2K. Regarding current trading prices, TSUSF is priced at $17.25, while AEGY trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSUSF currently has a P/E ratio of 41.07, whereas AEGY's P/E ratio is N/A. In terms of profitability, TSUSF's ROE is +0.12%, compared to AEGY's ROE of +0.00%. Regarding short-term risk, TSUSF and AEGY have similar daily volatility (0.00).Check AEGY's competition here
TSUSF vs IPAH Comparison April 2026
TSUSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSUSF stands at 4.2B. In comparison, IPAH has a market cap of 270.8K. Regarding current trading prices, TSUSF is priced at $17.25, while IPAH trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSUSF currently has a P/E ratio of 41.07, whereas IPAH's P/E ratio is -0.05. In terms of profitability, TSUSF's ROE is +0.12%, compared to IPAH's ROE of -0.82%. Regarding short-term risk, TSUSF is less volatile compared to IPAH. This indicates potentially lower risk in terms of short-term price fluctuations for TSUSF.Check IPAH's competition here
TSUSF vs IMMB Comparison April 2026
TSUSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSUSF stands at 4.2B. In comparison, IMMB has a market cap of 115K. Regarding current trading prices, TSUSF is priced at $17.25, while IMMB trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSUSF currently has a P/E ratio of 41.07, whereas IMMB's P/E ratio is N/A. In terms of profitability, TSUSF's ROE is +0.12%, compared to IMMB's ROE of -0.09%. Regarding short-term risk, TSUSF is less volatile compared to IMMB. This indicates potentially lower risk in terms of short-term price fluctuations for TSUSF.Check IMMB's competition here
TSUSF vs FOGCF Comparison April 2026
TSUSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSUSF stands at 4.2B. In comparison, FOGCF has a market cap of 97.2K. Regarding current trading prices, TSUSF is priced at $17.25, while FOGCF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSUSF currently has a P/E ratio of 41.07, whereas FOGCF's P/E ratio is N/A. In terms of profitability, TSUSF's ROE is +0.12%, compared to FOGCF's ROE of +3.99%. Regarding short-term risk, TSUSF is less volatile compared to FOGCF. This indicates potentially lower risk in terms of short-term price fluctuations for TSUSF.Check FOGCF's competition here
TSUSF vs MDIN Comparison April 2026
TSUSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSUSF stands at 4.2B. In comparison, MDIN has a market cap of 90.3K. Regarding current trading prices, TSUSF is priced at $17.25, while MDIN trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSUSF currently has a P/E ratio of 41.07, whereas MDIN's P/E ratio is N/A. In terms of profitability, TSUSF's ROE is +0.12%, compared to MDIN's ROE of +0.36%. Regarding short-term risk, TSUSF is less volatile compared to MDIN. This indicates potentially lower risk in terms of short-term price fluctuations for TSUSF.Check MDIN's competition here
TSUSF vs OXIHF Comparison April 2026
TSUSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSUSF stands at 4.2B. In comparison, OXIHF has a market cap of 72K. Regarding current trading prices, TSUSF is priced at $17.25, while OXIHF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSUSF currently has a P/E ratio of 41.07, whereas OXIHF's P/E ratio is N/A. In terms of profitability, TSUSF's ROE is +0.12%, compared to OXIHF's ROE of +3.30%. Regarding short-term risk, TSUSF is less volatile compared to OXIHF. This indicates potentially lower risk in terms of short-term price fluctuations for TSUSF.Check OXIHF's competition here
TSUSF vs LGNXZ Comparison April 2026
TSUSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSUSF stands at 4.2B. In comparison, LGNXZ has a market cap of 57.8K. Regarding current trading prices, TSUSF is priced at $17.25, while LGNXZ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSUSF currently has a P/E ratio of 41.07, whereas LGNXZ's P/E ratio is N/A. In terms of profitability, TSUSF's ROE is +0.12%, compared to LGNXZ's ROE of +0.14%. Regarding short-term risk, TSUSF and LGNXZ have similar daily volatility (0.00).Check LGNXZ's competition here
TSUSF vs HADV Comparison April 2026
TSUSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSUSF stands at 4.2B. In comparison, HADV has a market cap of 48.3K. Regarding current trading prices, TSUSF is priced at $17.25, while HADV trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSUSF currently has a P/E ratio of 41.07, whereas HADV's P/E ratio is N/A. In terms of profitability, TSUSF's ROE is +0.12%, compared to HADV's ROE of +0.18%. Regarding short-term risk, TSUSF and HADV have similar daily volatility (0.00).Check HADV's competition here
TSUSF vs AXMP Comparison April 2026
TSUSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSUSF stands at 4.2B. In comparison, AXMP has a market cap of 40.9K. Regarding current trading prices, TSUSF is priced at $17.25, while AXMP trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSUSF currently has a P/E ratio of 41.07, whereas AXMP's P/E ratio is 0.05. In terms of profitability, TSUSF's ROE is +0.12%, compared to AXMP's ROE of N/A. Regarding short-term risk, TSUSF and AXMP have similar daily volatility (0.00).Check AXMP's competition here
TSUSF vs LGNDZ Comparison April 2026
TSUSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSUSF stands at 4.2B. In comparison, LGNDZ has a market cap of 36.1K. Regarding current trading prices, TSUSF is priced at $17.25, while LGNDZ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSUSF currently has a P/E ratio of 41.07, whereas LGNDZ's P/E ratio is N/A. In terms of profitability, TSUSF's ROE is +0.12%, compared to LGNDZ's ROE of +0.14%. Regarding short-term risk, TSUSF is less volatile compared to LGNDZ. This indicates potentially lower risk in terms of short-term price fluctuations for TSUSF.Check LGNDZ's competition here
TSUSF vs DECN Comparison April 2026
TSUSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSUSF stands at 4.2B. In comparison, DECN has a market cap of 35.5K. Regarding current trading prices, TSUSF is priced at $17.25, while DECN trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSUSF currently has a P/E ratio of 41.07, whereas DECN's P/E ratio is N/A. In terms of profitability, TSUSF's ROE is +0.12%, compared to DECN's ROE of -103.89%. Regarding short-term risk, TSUSF and DECN have similar daily volatility (0.00).Check DECN's competition here
TSUSF vs SPPH Comparison April 2026
TSUSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSUSF stands at 4.2B. In comparison, SPPH has a market cap of 29.4K. Regarding current trading prices, TSUSF is priced at $17.25, while SPPH trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSUSF currently has a P/E ratio of 41.07, whereas SPPH's P/E ratio is -0.03. In terms of profitability, TSUSF's ROE is +0.12%, compared to SPPH's ROE of -0.50%. Regarding short-term risk, TSUSF is less volatile compared to SPPH. This indicates potentially lower risk in terms of short-term price fluctuations for TSUSF.Check SPPH's competition here
TSUSF vs OMHE Comparison April 2026
TSUSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSUSF stands at 4.2B. In comparison, OMHE has a market cap of 29.3K. Regarding current trading prices, TSUSF is priced at $17.25, while OMHE trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSUSF currently has a P/E ratio of 41.07, whereas OMHE's P/E ratio is N/A. In terms of profitability, TSUSF's ROE is +0.12%, compared to OMHE's ROE of +0.73%. Regarding short-term risk, TSUSF is less volatile compared to OMHE. This indicates potentially lower risk in terms of short-term price fluctuations for TSUSF.Check OMHE's competition here
TSUSF vs SCRCQ Comparison April 2026
TSUSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSUSF stands at 4.2B. In comparison, SCRCQ has a market cap of 14.1K. Regarding current trading prices, TSUSF is priced at $17.25, while SCRCQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSUSF currently has a P/E ratio of 41.07, whereas SCRCQ's P/E ratio is -0.01. In terms of profitability, TSUSF's ROE is +0.12%, compared to SCRCQ's ROE of +1.63%. Regarding short-term risk, TSUSF is less volatile compared to SCRCQ. This indicates potentially lower risk in terms of short-term price fluctuations for TSUSF.Check SCRCQ's competition here
TSUSF vs TSTS Comparison April 2026
TSUSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSUSF stands at 4.2B. In comparison, TSTS has a market cap of 12.8K. Regarding current trading prices, TSUSF is priced at $17.25, while TSTS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSUSF currently has a P/E ratio of 41.07, whereas TSTS's P/E ratio is N/A. In terms of profitability, TSUSF's ROE is +0.12%, compared to TSTS's ROE of +2.32%. Regarding short-term risk, TSUSF is less volatile compared to TSTS. This indicates potentially lower risk in terms of short-term price fluctuations for TSUSF.Check TSTS's competition here
TSUSF vs IXSBF Comparison April 2026
TSUSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSUSF stands at 4.2B. In comparison, IXSBF has a market cap of 12.6K. Regarding current trading prices, TSUSF is priced at $17.25, while IXSBF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSUSF currently has a P/E ratio of 41.07, whereas IXSBF's P/E ratio is -0.01. In terms of profitability, TSUSF's ROE is +0.12%, compared to IXSBF's ROE of +1.90%. Regarding short-term risk, TSUSF is less volatile compared to IXSBF. This indicates potentially lower risk in terms of short-term price fluctuations for TSUSF.Check IXSBF's competition here
TSUSF vs VIAP Comparison April 2026
TSUSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSUSF stands at 4.2B. In comparison, VIAP has a market cap of 10.3K. Regarding current trading prices, TSUSF is priced at $17.25, while VIAP trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSUSF currently has a P/E ratio of 41.07, whereas VIAP's P/E ratio is -0.05. In terms of profitability, TSUSF's ROE is +0.12%, compared to VIAP's ROE of +0.65%. Regarding short-term risk, TSUSF is less volatile compared to VIAP. This indicates potentially lower risk in terms of short-term price fluctuations for TSUSF.Check VIAP's competition here
TSUSF vs ALST Comparison April 2026
TSUSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSUSF stands at 4.2B. In comparison, ALST has a market cap of 8.4K. Regarding current trading prices, TSUSF is priced at $17.25, while ALST trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSUSF currently has a P/E ratio of 41.07, whereas ALST's P/E ratio is N/A. In terms of profitability, TSUSF's ROE is +0.12%, compared to ALST's ROE of +0.07%. Regarding short-term risk, TSUSF and ALST have similar daily volatility (0.00).Check ALST's competition here
TSUSF vs HTPRF Comparison April 2026
TSUSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSUSF stands at 4.2B. In comparison, HTPRF has a market cap of 8.2K. Regarding current trading prices, TSUSF is priced at $17.25, while HTPRF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSUSF currently has a P/E ratio of 41.07, whereas HTPRF's P/E ratio is N/A. In terms of profitability, TSUSF's ROE is +0.12%, compared to HTPRF's ROE of +0.09%. Regarding short-term risk, TSUSF is less volatile compared to HTPRF. This indicates potentially lower risk in terms of short-term price fluctuations for TSUSF.Check HTPRF's competition here
TSUSF vs HBOSF Comparison April 2026
TSUSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSUSF stands at 4.2B. In comparison, HBOSF has a market cap of 7.8K. Regarding current trading prices, TSUSF is priced at $17.25, while HBOSF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSUSF currently has a P/E ratio of 41.07, whereas HBOSF's P/E ratio is 0.03. In terms of profitability, TSUSF's ROE is +0.12%, compared to HBOSF's ROE of +6.69%. Regarding short-term risk, TSUSF and HBOSF have similar daily volatility (0.00).Check HBOSF's competition here
TSUSF vs WPHM Comparison April 2026
TSUSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSUSF stands at 4.2B. In comparison, WPHM has a market cap of 7.7K. Regarding current trading prices, TSUSF is priced at $17.25, while WPHM trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSUSF currently has a P/E ratio of 41.07, whereas WPHM's P/E ratio is N/A. In terms of profitability, TSUSF's ROE is +0.12%, compared to WPHM's ROE of -1.56%. Regarding short-term risk, TSUSF and WPHM have similar daily volatility (0.00).Check WPHM's competition here
TSUSF vs PXYN Comparison April 2026
TSUSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSUSF stands at 4.2B. In comparison, PXYN has a market cap of 6.3K. Regarding current trading prices, TSUSF is priced at $17.25, while PXYN trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSUSF currently has a P/E ratio of 41.07, whereas PXYN's P/E ratio is N/A. In terms of profitability, TSUSF's ROE is +0.12%, compared to PXYN's ROE of -0.20%. Regarding short-term risk, TSUSF is less volatile compared to PXYN. This indicates potentially lower risk in terms of short-term price fluctuations for TSUSF.Check PXYN's competition here
TSUSF vs IYXI Comparison April 2026
TSUSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSUSF stands at 4.2B. In comparison, IYXI has a market cap of 5.2K. Regarding current trading prices, TSUSF is priced at $17.25, while IYXI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSUSF currently has a P/E ratio of 41.07, whereas IYXI's P/E ratio is N/A. In terms of profitability, TSUSF's ROE is +0.12%, compared to IYXI's ROE of +1.71%. Regarding short-term risk, TSUSF and IYXI have similar daily volatility (0.00).Check IYXI's competition here
TSUSF vs RBII Comparison April 2026
TSUSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSUSF stands at 4.2B. In comparison, RBII has a market cap of 5K. Regarding current trading prices, TSUSF is priced at $17.25, while RBII trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSUSF currently has a P/E ratio of 41.07, whereas RBII's P/E ratio is N/A. In terms of profitability, TSUSF's ROE is +0.12%, compared to RBII's ROE of -0.04%. Regarding short-term risk, TSUSF is less volatile compared to RBII. This indicates potentially lower risk in terms of short-term price fluctuations for TSUSF.Check RBII's competition here
TSUSF vs CXBS Comparison April 2026
TSUSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSUSF stands at 4.2B. In comparison, CXBS has a market cap of 2.7K. Regarding current trading prices, TSUSF is priced at $17.25, while CXBS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSUSF currently has a P/E ratio of 41.07, whereas CXBS's P/E ratio is N/A. In terms of profitability, TSUSF's ROE is +0.12%, compared to CXBS's ROE of +0.00%. Regarding short-term risk, TSUSF is less volatile compared to CXBS. This indicates potentially lower risk in terms of short-term price fluctuations for TSUSF.Check CXBS's competition here
TSUSF vs NEWG Comparison April 2026
TSUSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSUSF stands at 4.2B. In comparison, NEWG has a market cap of 2.3K. Regarding current trading prices, TSUSF is priced at $17.25, while NEWG trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSUSF currently has a P/E ratio of 41.07, whereas NEWG's P/E ratio is N/A. In terms of profitability, TSUSF's ROE is +0.12%, compared to NEWG's ROE of +0.40%. Regarding short-term risk, TSUSF is less volatile compared to NEWG. This indicates potentially lower risk in terms of short-term price fluctuations for TSUSF.Check NEWG's competition here
TSUSF vs FSPM Comparison April 2026
TSUSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSUSF stands at 4.2B. In comparison, FSPM has a market cap of 1.3K. Regarding current trading prices, TSUSF is priced at $17.25, while FSPM trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSUSF currently has a P/E ratio of 41.07, whereas FSPM's P/E ratio is N/A. In terms of profitability, TSUSF's ROE is +0.12%, compared to FSPM's ROE of N/A. Regarding short-term risk, TSUSF and FSPM have similar daily volatility (0.00).Check FSPM's competition here
TSUSF vs GRPI Comparison April 2026
TSUSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSUSF stands at 4.2B. In comparison, GRPI has a market cap of 1K. Regarding current trading prices, TSUSF is priced at $17.25, while GRPI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSUSF currently has a P/E ratio of 41.07, whereas GRPI's P/E ratio is -0.02. In terms of profitability, TSUSF's ROE is +0.12%, compared to GRPI's ROE of +0.09%. Regarding short-term risk, TSUSF and GRPI have similar daily volatility (0.00).Check GRPI's competition here
TSUSF vs KIARF Comparison April 2026
TSUSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSUSF stands at 4.2B. In comparison, KIARF has a market cap of 442. Regarding current trading prices, TSUSF is priced at $17.25, while KIARF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSUSF currently has a P/E ratio of 41.07, whereas KIARF's P/E ratio is N/A. In terms of profitability, TSUSF's ROE is +0.12%, compared to KIARF's ROE of -1.47%. Regarding short-term risk, TSUSF is less volatile compared to KIARF. This indicates potentially lower risk in terms of short-term price fluctuations for TSUSF.Check KIARF's competition here
TSUSF vs ACGJ Comparison April 2026
TSUSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSUSF stands at 4.2B. In comparison, ACGJ has a market cap of 324. Regarding current trading prices, TSUSF is priced at $17.25, while ACGJ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSUSF currently has a P/E ratio of 41.07, whereas ACGJ's P/E ratio is -0.00. In terms of profitability, TSUSF's ROE is +0.12%, compared to ACGJ's ROE of N/A. Regarding short-term risk, TSUSF and ACGJ have similar daily volatility (0.00).Check ACGJ's competition here
TSUSF vs MDVLQ Comparison April 2026
TSUSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSUSF stands at 4.2B. In comparison, MDVLQ has a market cap of 161. Regarding current trading prices, TSUSF is priced at $17.25, while MDVLQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSUSF currently has a P/E ratio of 41.07, whereas MDVLQ's P/E ratio is N/A. In terms of profitability, TSUSF's ROE is +0.12%, compared to MDVLQ's ROE of -2.39%. Regarding short-term risk, TSUSF is less volatile compared to MDVLQ. This indicates potentially lower risk in terms of short-term price fluctuations for TSUSF.Check MDVLQ's competition here
TSUSF vs ISHI Comparison April 2026
TSUSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSUSF stands at 4.2B. In comparison, ISHI has a market cap of 5. Regarding current trading prices, TSUSF is priced at $17.25, while ISHI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSUSF currently has a P/E ratio of 41.07, whereas ISHI's P/E ratio is N/A. In terms of profitability, TSUSF's ROE is +0.12%, compared to ISHI's ROE of N/A. Regarding short-term risk, TSUSF is less volatile compared to ISHI. This indicates potentially lower risk in terms of short-term price fluctuations for TSUSF.Check ISHI's competition here
TSUSF vs SYNI Comparison April 2026
TSUSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSUSF stands at 4.2B. In comparison, SYNI has a market cap of 3. Regarding current trading prices, TSUSF is priced at $17.25, while SYNI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSUSF currently has a P/E ratio of 41.07, whereas SYNI's P/E ratio is -0.00. In terms of profitability, TSUSF's ROE is +0.12%, compared to SYNI's ROE of N/A. Regarding short-term risk, TSUSF and SYNI have similar daily volatility (0.00).Check SYNI's competition here
TSUSF vs GHTI Comparison April 2026
TSUSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSUSF stands at 4.2B. In comparison, GHTI has a market cap of 0. Regarding current trading prices, TSUSF is priced at $17.25, while GHTI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSUSF currently has a P/E ratio of 41.07, whereas GHTI's P/E ratio is N/A. In terms of profitability, TSUSF's ROE is +0.12%, compared to GHTI's ROE of N/A. Regarding short-term risk, TSUSF is less volatile compared to GHTI. This indicates potentially lower risk in terms of short-term price fluctuations for TSUSF.Check GHTI's competition here
TSUSF vs MDSI Comparison April 2026
TSUSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSUSF stands at 4.2B. In comparison, MDSI has a market cap of 0. Regarding current trading prices, TSUSF is priced at $17.25, while MDSI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSUSF currently has a P/E ratio of 41.07, whereas MDSI's P/E ratio is N/A. In terms of profitability, TSUSF's ROE is +0.12%, compared to MDSI's ROE of N/A. Regarding short-term risk, TSUSF and MDSI have similar daily volatility (0.00).Check MDSI's competition here
TSUSF vs MMCWF Comparison April 2026
TSUSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSUSF stands at 4.2B. In comparison, MMCWF has a market cap of 0. Regarding current trading prices, TSUSF is priced at $17.25, while MMCWF trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSUSF currently has a P/E ratio of 41.07, whereas MMCWF's P/E ratio is N/A. In terms of profitability, TSUSF's ROE is +0.12%, compared to MMCWF's ROE of N/A. Regarding short-term risk, TSUSF and MMCWF have similar daily volatility (0.00).Check MMCWF's competition here
TSUSF vs TFSHF Comparison April 2026
TSUSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TSUSF stands at 4.2B. In comparison, TFSHF has a market cap of 0. Regarding current trading prices, TSUSF is priced at $17.25, while TFSHF trades at $1.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TSUSF currently has a P/E ratio of 41.07, whereas TFSHF's P/E ratio is N/A. In terms of profitability, TSUSF's ROE is +0.12%, compared to TFSHF's ROE of N/A. Regarding short-term risk, TSUSF and TFSHF have similar daily volatility (0.00).Check TFSHF's competition here